Chronic Obstructive Pulmonary Disease As a Risk Factor for Cardiovascular Disease. A View from the SUMMIT
Overview
Authors
Affiliations
Simons S, Heptinstall A, Marjenberg Z, Marshall J, Mullerova H, Rogliani P Int J Chron Obstruct Pulmon Dis. 2024; 19:2259-2271.
PMID: 39411574 PMC: 11474009. DOI: 10.2147/COPD.S466280.
Swart K, Baak B, Lemmens L, Penning-van Beest F, Bengtsson C, Lobier M Respir Res. 2023; 24(1):293.
PMID: 37990197 PMC: 10662240. DOI: 10.1186/s12931-023-02601-4.
Nordon C, Rhodes K, Quint J, Vogelmeier C, Simons S, Hawkins N BMJ Open. 2023; 13(4):e070022.
PMID: 37185641 PMC: 10151875. DOI: 10.1136/bmjopen-2022-070022.
A Nomogram for Predicting Cardiovascular Diseases in Chronic Obstructive Pulmonary Disease Patients.
Qu S, Zhu J J Healthc Eng. 2022; 2022:6394290.
PMID: 36304748 PMC: 9596246. DOI: 10.1155/2022/6394290.
Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease.
Li N, Dai Z, Wang Z, Deng Z, Zhang J, Pu J Respir Res. 2021; 22(1):274.
PMID: 34696775 PMC: 8543848. DOI: 10.1186/s12931-021-01872-z.